Vestal Point Capital’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-500,000	Closed	-$11.6M	–	74
2024 Q2	$11.6M	Buy	+500,000	New	+$11.6M	0.87%	33